MUSCULAR DYSTROPHY, DUCHENNE
Clinical trials for MUSCULAR DYSTROPHY, DUCHENNE explained in plain language.
Never miss a new study
Get alerted when new MUSCULAR DYSTROPHY, DUCHENNE trials appear
Sign up with your email to follow new studies for MUSCULAR DYSTROPHY, DUCHENNE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for duchenne: major trial tests cell therapy to preserve muscle function
Disease control OngoingThis study is testing whether a cell therapy called deramiocel can slow the loss of muscle function in boys and young men with Duchenne muscular dystrophy (DMD). About 106 participants will receive either the therapy or a placebo via IV infusion every three months for a year, wit…
Matched conditions: MUSCULAR DYSTROPHY, DUCHENNE
Phase: PHASE3 • Sponsor: Capricor Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Race against time: High-Dose drug trial aims to keep boys walking longer
Disease control OngoingThis study is testing whether higher doses of the drug eteplirsen are safe and more effective at slowing muscle decline in boys with Duchenne muscular dystrophy (DMD). It involves about 160 boys aged 4 and older who can still walk and have a specific genetic mutation. The main go…
Matched conditions: MUSCULAR DYSTROPHY, DUCHENNE
Phase: PHASE3 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC